Literature DB >> 22647884

Investigation of antibodies against synaptic proteins in a cross-sectional cohort of psychotic patients.

Ida S Haussleiter, Barbara Emons, Markus Schaub, Kathrin Borowski, Martin Brüne, Klaus-Peter Wandinger, Georg Juckel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22647884     DOI： 10.1016/j.schres.2012.05.006

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  11 in total

Review 1.  Antineuronal antibodies against neurotransmitter receptors and synaptic proteins in schizophrenia: current knowledge and clinical implications.

Authors:  Johann Steiner; Kolja Schiltz; Hans-Gert Bernstein; Bernhard Bogerts
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749

Review 2.  Anti-NMDA receptor encephalitis, autoimmunity, and psychosis.

Authors:  Matthew S Kayser; Josep Dalmau
Journal:  Schizophr Res       Date:  2014-10-25       Impact factor: 4.939

3.  Anti-NMDA receptor antibodies in patients with a first episode of schizophrenia.

Authors:  Jiří Masopust; Ctirad Andrýs; Jan Bažant; Oldřich Vyšata; Kamil Kuca; Martin Vališ
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-06       Impact factor: 2.570

4.  Prevalence of elevated serum anti-N-methyl-D-aspartate receptor antibody titers in patients presenting exclusively with psychiatric symptoms: a comparative follow-up study.

Authors:  Yoshihito Ando; Haruo Shimazaki; Katsutoshi Shiota; Syuichi Tetsuka; Koichi Nakao; Tatsuhiro Shimada; Kazumi Kurata; Jinichi Kuroda; Akihiro Yamashita; Hayato Sato; Mamoru Sato; Shinkichi Eto; Yasunori Onishi; Keiko Tanaka; Satoshi Kato
Journal:  BMC Psychiatry       Date:  2016-07-08       Impact factor: 3.630

5.  Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients.

Authors:  Julie Jézéquel; Emily M Johansson; Julien P Dupuis; Véronique Rogemond; Hélène Gréa; Blanka Kellermayer; Nora Hamdani; Emmanuel Le Guen; Corentin Rabu; Marilyn Lepleux; Marianna Spatola; Elodie Mathias; Delphine Bouchet; Amy J Ramsey; Robert H Yolken; Ryad Tamouza; Josep Dalmau; Jérôme Honnorat; Marion Leboyer; Laurent Groc
Journal:  Nat Commun       Date:  2017-11-27       Impact factor: 14.919

6.  The Clinical Challenge of Autoimmune Psychosis: Learning from Anti-NMDA Receptor Autoantibodies.

Authors:  Pierre Ellul; Laurent Groc; Ryad Tamouza; Marion Leboyer
Journal:  Front Psychiatry       Date:  2017-04-19       Impact factor: 4.157

7.  The role of NMDAR antibody in the etiopathogenesis of schizophrenia.

Authors:  Damla Timucin; Osman Ozdemir; Mehmet Parlak
Journal:  Neuropsychiatr Dis Treat       Date:  2016-09-13       Impact factor: 2.570

8.  Increased serum anti-N-methyl-D-aspartate receptor antibody immunofluorescence in psychiatric patients with past catatonia.

Authors:  Chin-Chuen Lin; Yi-Yung Hung; Meng-Chang Tsai; Tiao-Lai Huang
Journal:  PLoS One       Date:  2017-10-26       Impact factor: 3.240

9.  Pathogen-mediated NMDA receptor autoimmunity and cellular barrier dysfunction in schizophrenia.

Authors:  G Kannan; K L Gressitt; S Yang; C R Stallings; E Katsafanas; L A Schweinfurth; C L G Savage; M B Adamos; K M Sweeney; A E Origoni; S Khushalani; S Bahn; F M Leweke; F B Dickerson; R H Yolken; M V Pletnikov; E G Severance
Journal:  Transl Psychiatry       Date:  2017-08-01       Impact factor: 6.222

Review 10.  Autoimmune phenotypes in schizophrenia reveal novel treatment targets.

Authors:  Emily G Severance; Faith B Dickerson; Robert H Yolken
Journal:  Pharmacol Ther       Date:  2018-05-06       Impact factor: 12.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.